http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
nucleic acid testing (NAT) to reduce the possible risk of parvovirus B19 transmission by plasma-derived products
Center for Biologics Evaluation and Research (U.S.)
Title from PDF title page (viewed on Apr. 21, 2009).
Mode of access: Internet at the FDA CBER Web site. Address as of 4/21/09: http://www.fda.gov/cber/gdlns/natparo.pdf ; current access is available via PURL.
Includes bibliographical references (pages 4-5).